Vulnerable Plaque


Also found in: Wikipedia.
An atheromatous plaque in an arterial wall, which has abundant macrophages, gobs of lipids and cholesterol, and is usually covered by a thin fibrous cap which may rupture. The repeated cycle of rupture and healing is regarded as the major mechanism of arterial stenosis in atherosclerotic heart disease, myocardial infarction and strokes
References in periodicals archive ?
Therefore, advances in image fusion are required to merge the different plaque components into one single 3D vulnerable plaque reconstruction.
A biomarker of vulnerable plaque would allow the possibility to better target preventive measures against plaque rupture and thereby decrease the occurrence of ACS; however, are there really biomarkers of vulnerable plaque?
Angel Medical Systems previously developed the AngelMed Guardian cardiac monitor and alert system, which detects and warns patients of acute episodes of cardiac ischemia related to the progression of coronary artery disease and thrombotic coronary occlusion caused by vulnerable plaque ruptures.
The vulnerable plaque is the cause of most heart attacks and strokes.
PROSPECT is the first prospective natural history study to evaluate the role of vulnerable plaque in unexpected heart attacks and the natural progression of coronary artery disease.
It is believed that patients with inflammatory disease, including SLE, are more likely to have vulnerable plaque rupture, accounting for more frequent events.
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies.
Key Words: electron beam computed tomography, intravascular ultrasound, magnetic resonance imaging, thermography, vulnerable plaque
In addition, PharmaSonics is building its intellectual property portfolio to expand the application of Sonotherapy for the treatment of vulnerable plaque and use with drug-eluting stents.
We continue to make progress in pursuing new applications of our core technology, such as use of vascular brachytherapy in peripheral artery disease, arterial-venous dialysis graft stenosis, and the treatment of vulnerable plaque.
This report details the responses of a comprehensive survey conducted of interventional cardiologists, interventional radiologists and cardiac surgeons on product preferences, placement techniques and trends in the use of drug eluting and bare metal stents, bifurcated stents, bioabsorbable stents, stent grafts, vulnerable plaque diagnosis and treatment and endovascular imaging technologies.